Relay Therapeutics, Inc. · NASDAQ:RLAY
Commodore Capital LP reported a 7.80% stake in Relay Therapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 14, 2025
Commodore Capital LP reported a 7.80% stake in Relay Therapeutics, Inc., 13,350,000 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).
- Stake
- 7.80%
- Shares
- 13,350,000
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Commodore Capital LP | 7.80% | 13,350,000 |
| Commodore Capital Master LP | 7.80% | 13,350,000 |
| Robert Egen Atkinson | 7.80% | 13,350,000 |
| Michael Kramarz | 7.80% | 13,350,000 |
Source
Related
- Relay Therapeutics, Inc.
- Commodore Capital LP
- Relay Therapeutics, Inc. shareholders
- Schedule 13G/A · Commodore Capital LP · Aug 14, 2026
- Schedule 13G/A · Commodore Capital LP · Nov 14, 2025
- Schedule 13G · Commodore Capital LP · May 15, 2025
- Form 4 · Patel Sanjiv · Oct 8, 2026
- Form 4 · Catinazzo Thomas · Oct 8, 2026
- Form 4 · Bergstrom Donald A · Sep 9, 2026
- Form 4 · Catinazzo Thomas · Sep 9, 2026
- Form 4 · Patel Sanjiv · Sep 9, 2026